Drug Type Unknown |
Synonyms- |
Target |
Mechanism IL-2 inhibitors(Interleukin-2 inhibitors), Immunomodulators, Regulatory T-lymphocytes modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization Egle Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | - | Egle Therapeutics SASStartup | - |
Neoplasms | Discovery | - | Egle Therapeutics SASStartup | - |